cbdMD (YCBD) EPS (Basic) (2016 - 2025)

cbdMD has disclosed EPS (Basic) across 10 years of filings, most recently posting -$0.04 for Q4 2025.

• EPS (Basic) for Q4 2025 came in at -$0.04, up 97.69% year-over-year; the trailing twelve-month figure through Dec 2025 was -$117.38 (up 43.79% YoY), and the FY2025 annual result was -$741.47, up 40.64% from the prior year.
• EPS (Basic) came in at -$0.04 for Q4 2025 at cbdMD, up from -$115.23 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.02 in Q2 2021 to a low of -$335.44 in Q3 2023.
• The 5-year median for EPS (Basic) is -$0.92 (2023), against an average of -$33.52.
• Across the five-year window, EPS (Basic) jumped 111.11% in 2021 and tumbled 134074.29% in 2023, its largest moves.
• cbdMD's EPS (Basic) stood at -$0.35 in 2021, then slumped by 957.14% to -$3.7 in 2022, then jumped by 81.89% to -$0.67 in 2023, then slumped by 158.21% to -$1.73 in 2024, then surged by 97.69% to -$0.04 in 2025.
• The last three EPS (Basic) figures came in at -$0.04 (Q4 2025), -$115.23 (Q3 2025), and -$0.21 (Q2 2025), per Business Quant data.